Immunopharmacology
IRTB - Arterial Access and Angioplasty Dr Hilary White Nottingham.
Is Coronary Artery Bypass Surgery Really Better than Coronary Stents? A look at the risks and benefits Sarah Smith Advisor: Dr. Grimes.
Clemens von Birgelen 1,2, Hanim Sen 1, Ming Kai Lam 1, Peter W. Danse 3, Gillian A.J. Jessurun 4, Raymond W.M. Hautvast 5, K. Gert van Houwelingen 1, Alexander.
Should DES be the chosen one? Class 22, 1st year Adviser: Prof. Filipa Almeida Class 22, 1st year Adviser: Prof. Filipa Almeida Authors: Aguiar, A.; Alves,
PCOMS Winter Conference Ronald L Walsh, D.O. The Heart Institute at Largo January 29, 2015.
BY: COURTNEY MEDEIROS BME 281 11/30/11 Coronary Stents.
Presenter Disclosure No conflict of interest Anthony Fung The BRIEF-PCI Trial.
Jeffrey J. Popma, MD Klaus A. Tiroch, MD Brigham and Women’s Hospital Harvard Medical School Boston, MA CYPHER™ Stent Fracture: An Uncommon Complication.
Basic Principles of FDA Medical Device Regulation and How FDA Might Have Handled the Recent PIP Crisis British Institute of International and Comparative.
Bare Metal vs Drug Eluting Stents
October 2011
